In the latest installment of ACC Cardiology Hour, Valentin Fuster, MD, PhD, MACC, as well as expert panelists Clyde Yancy, MD, MSc, MACC; Rasha Al-Lamee, MD, PhD; Julia Indik, MD, PhD, FACC; and Vinod Thourani, MD, FACC, discuss the top late-breaking clinical trials released during ACC.24. Introduction – (00:00). Don’t miss key takeaways and expert analysis on the practice implications of RELIEVE-HF (02:23), EMPACT-MI (12:48), The DanGer-Shock Trial (20:19), AEGIS-II CSL112 (28:12), Phase 2 Kardia 2 (37:10), PREVENTIVE-PCI (46:19), ORBITA-COSMIC (53:37), and IMPROVE-HCM (1:01:02). Additionally, watch the “Best of ACC.24” pick from each panelist (1:06:06).
Visit https://www.JACC.org/CardiologyHour to see more videos. Related links: For ACC coverage of ACC24, visit https://www.acc.org/latest-in-cardiol...
#JACC #JACCJournals #ACC24